PHARMA-BIO SERV, INC. Cash and Restricted Cash
PHARMA-BIO SERV, INC. (PBSV) had Cash and Restricted Cash of $1.52 million as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-14
- 2026-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.52M.
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.79M.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.76M.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.38M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-31 | $1.52M 10-Q · filed 2026-09-14 |
| 2026-04-30 | $1.79M 10-Q · filed 2026-09-14 |
| 2026-01-31 | $5.76M 10-Q · filed 2026-06-15 |
| 2025-10-31 | $3.38M 10-Q · filed 2026-09-14 |
| 2025-07-31 | $3.96M 10-Q · filed 2026-09-14 |
| 2025-04-30 | $2.09M 10-Q · filed 2026-09-14 |
| 2025-01-31 | $7.31M 10-Q · filed 2026-06-15 |
| 2024-10-31 | $6.77M 10-Q · filed 2026-09-14 |
| 2024-07-31 | $6.52M 10-Q · filed 2025-09-15 |
| 2024-04-30 | $3.51M 10-Q · filed 2025-09-15 |
| 2024-01-31 | $6.41M 10-Q · filed 2025-06-16 |
| 2023-10-31 | $10.45M 10-K · filed 2026-01-29 |
| 2023-07-31 | $2.87M 10-Q · filed 2024-09-16 |
| 2023-04-30 | $8.10M 10-Q · filed 2024-09-16 |
| 2023-01-31 | $7.23M 10-Q · filed 2024-06-14 |
| 2022-10-31 | $14.46M 10-K · filed 2025-01-29 |
| 2022-07-31 | $14.24M 10-Q · filed 2023-09-14 |
| 2022-04-30 | $13.16M 10-Q · filed 2023-09-14 |
| 2022-01-31 | $15.35M 10-Q · filed 2023-06-14 |
| 2021-10-31 | $17.47M 10-K · filed 2024-01-29 |
| 2021-07-31 | $16.50M 10-Q · filed 2022-09-14 |
| 2021-04-30 | $16.07M 10-Q · filed 2022-09-14 |
| 2021-01-31 | $18.99M 10-Q · filed 2022-06-14 |
| 2020-10-31 | $17.14M 10-K · filed 2023-01-30 |